I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Third molar (M3) removal is one of the frequent procedure in daily oral surgery (OS) practice. In few patients, inflammatory complications were observed after its removal. Even though complications are rare, owing to the large number of M3 extractions, these complications must be considered seriously and measures must be taken to limit them. One such measure adopted commonly by oral surgeons to reduce complications is by prescribing antibiotics. Few studies showed favorable effects of antibiotics in lowering postoperative inflammatory complications.\[[@ref1][@ref2]\] However few others did not showed any beneficial effects.\[[@ref3][@ref4]\]

Marcussen *et al*.\[[@ref5]\] in their systematic review showed that a single preoperative dose of amoxicillin lessened the occurrence of surgical site infection (SSI) and a single dose of penicillin lessened alveolar osteitis (AO) incidence. We carried out our study to verify the relation between postoperative antibiotic usage and inflammatory complications (SSI or AO) after M3 removal. Our hypothesis was that postoperative antibiotics will lessen inflammatory complications.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

We carried a prospective cohort study. We derived the sample from the enrolled patients in a Practice-Based Research Collaborative (P-BRC) of Saudi Arabia private practitioners who were oral surgeons, from January 1, 2017, to May 31, 2018.

Inclusion criteria {#sec2-1}
------------------

Patients who underwent M3 removalPatients whose postoperative data were available

Exclusion criteria {#sec2-2}
------------------

Dental practitioners other than oral surgeonsDental practitioners outside Saudi ArabiaPatients with systemic diseases

The study has registered ethical committee approval and consent was obtained from all subjects (KFSH/E15A/2017). Sample size was determined from a similar studies using the formula: *n* = \[(z∝ + zβ)σd\]2. With a confidence interval of 95% and power of 95% for the study, a sample size of 35 was obtained. The sample was randomly categorized in to two study groups: group A, in whom postoperative antibiotic was given, and group B, where antibiotic was not prescribed. The observed primary variable was occurrence and type of inflammatory complication (AO or SSI) after M3 removal. SSI was considered if there was a frank purulence at the extraction site or edema postoperatively. AO was diagnosed on basis of a history of new-onset or increased pain after 36 h postoperatively and clinically at extraction site showing loss of blood clot with exposed bone. Other aspects assessed were gender, age, body mass index (BMI), habits, and medical history.

Before extractions, Preoperative Disease Severity Score (PDS) was assessed by adding the whole number of preoperative disease conditions such as caries, periodontal disease, infection, resorption, fracture, adjacent tooth pathology, or supra eruption. If M3 were disease free, a zero score was assigned. Similarly Operative Difficulty Score (ODS) was measured by a scale of 0 to 6 (0, M3 not extracted; 1, erupted, nonsurgical removal; 2, erupted, surgical; 3, impacted in soft tissue; 4, impacted in bone partially; 5, impacted in bone fully; 6, impacted in bone, complicated or difficult).

Thus obtained data were entered on a Microsoft Excel sheet and descriptive statistics were computed for all the study variables using SPSS 22.0 software program (SPSS® Statistics; IBM, Armonk, NY). A *P* value of less than 0.05 was treated as significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Thirty-five oral and maxillofacial surgeons took part in the P-BRC. A total of 972 patients were enrolled with 1396 third molars removed. When the desired data regarding whether antibiotic was used or not were considered, the sample reduced to 725 in whom 965 M3 were removed. We found that 455 (62.75%) patients have taken antibiotics postoperatively.

Demographic details showed that the mean age was 28 ± 14.8 years. We observed a very high male preponderance of 543 (74.89%). Mean BMI was 26.7 ± 6.3 kg/m^2^. Habit history revealed 114 patients (15.72%) were consuming tobacco in some or other forms. The average number of M3 removed per person was 1.33. The mean PDS per patient was 2.13 ± 2.1 and the mean ODS was 12.1 ± 6.3 \[[Table 1](#T1){ref-type="table"} and [Graph 1](#F1){ref-type="fig"}\].

###### 

Summary of study variables

  Variable                                                     Value
  ------------------------------------------------------------ --------------------
  Mean age                                                     28 ± 14.8 years
  No. of males                                                 543 (74.89%)
  No. of females                                               182 (25.11%)
  Mean BMI                                                     26.7 ± 6.3 kg/m^2^
  No. of patients with tobacco habit history                   114 (15.72%)
  No. of third molars removed per person                       1.33
  Mean PDS                                                     2.13 ± 2.1
  Mean ODS                                                     12.1 ± 6.3
  No. of patients who have taken antibiotics postoperatively   455 (62.75%)

![Summary of study variables](JPBS-11-13-g001){#F1}

Bivariate association among the antibiotic usage and study variables was tabulated \[[Table 2](#T2){ref-type="table"}\]. The variables age and PDS showed statistically significant relationship with the usage or not of antibiotic, whereas BMI, ODS, and presence or absence of complications were insignificant.

###### 

Bivariate analyses of all study variables versus postoperative antibiotic exposure

  Variable        Usage of antibiotic   *P* value      
  --------------- --------------------- -------------- -----------
  Age (years)     29.13 ± 4.56          27.31 ± 4.86   \<0.001\*
  Gender                                               
   Males          285 (52.49%)          258 (47.51%)   \<0.001\*
   Females        130 (71.43%)          52 (28.57%)    
  BMI (kg/m^2^)   26.62 ± 3.63          26.79 ± 3.42   0.5336
  ODS             11.92 ± 5.97          12.30 ± 5.89   0.7026
  PDS             2.49 ± 2.1            1.88 ± 1.8     0.0469\*
  Complications   18 (48.65)            19 (51.35%)    0.0677

\* = Significant

Bivariate association among the inflammatory complications and study variables was also tabulated \[[Table 3](#T3){ref-type="table"}\]. The variables gender, usage of tobacco, and ODS were associated with developing inflammatory complications, whereas age, BMI, and PDS were insignificant.

###### 

Bivariate analyses of all study variables versus postoperative inflammatory complications (surgical site infection or alveolar osteitis)

  Variable        Complications   *P* value      
  --------------- --------------- -------------- -----------
  Age (years)     29.01 ± 4.56    28.71 ± 4.86   0.7138
  Gender                                         
   Males          21 (56.75%)     522 (75.87%)   0.0016\*
   Females        16 (43.25%)     166 (24.13%)   
  BMI (kg/m^2^)   26.56 ± 3.54    26.80 ± 3.52   0.6864
  ODS             11.32 ± 5.72    13.08 ± 5.91   \<0.001\*
  PDS             2.11 ± 1.9      2.23 ± 2.12    0.4315
  Tobacco habit   33 (89.19%)     4 (10.81%)     0.0002\*

\* = Significant

Bivariate associations among antibiotic usage and inflammatory complications was recorded \[[Table 4](#T4){ref-type="table"} and [Graph 2](#F2){ref-type="fig"}\]. The association showed that 63.73% patients took antibiotics. Frequency of inflammatory complications in the antibiotic group alone was 2.92% compared with 17.27% in the nonantibiotic group (relative risk \[RR\] = 0.17; 95% confidence interval \[CI\] = 2.8131 to 18.1790; *P* = 0.022).

###### 

Postoperative antibiotic exposure versus postoperative inflammatory complications (alveolar osteitis or surgical site infection)

  Inflammatory Complication (AO or SSI)   Yes          No             Total
  --------------------------------------- ------------ -------------- --------------
  Yes---postoperative antibiotics         18 (2.48%)   597 (82.34%)   615 (84.82%)
  No antibiotics                          19 (2.62%)   91 (12.55%)    110 (15.18%)
  Total                                   37 (5.10%)   688 (94.89%)   725 (100%)

Relative risk = 0.17; 95% confidence interval, 0.0919 to 0.3125; *P* \< 0.001.

![Bar graph showing postoperative antibiotic exposure versus postoperative inflammatory complications (alveolar osteitis or surgical site infection)](JPBS-11-13-g002){#F2}

[Table 5](#T5){ref-type="table"} depicts the unadjusted association among antibiotic usage and AO. Incidence of AO in the antibiotic group was 4.0% compared with 6.3% in the nonantibiotic group (RR = 0.1677; 95% CI = 0.0854 to 0.3292; *P* \< 0.0001).

###### 

Postoperative antibiotic versus alveolar osteitis---unadjusted model

  Inflammatory complication (AO)        Yes          No             Total
  ------------------------------------- ------------ -------------- --------------
  Yes---postoperative antibiotic only   15 (2.06%)   600 (82.75%)   615 (84.82%)
  No antibiotics                        16 (2.20%)   94 (12.96%)    110 (15.18%)
  Total                                 31 (4.26%)   694 (95.74%)   725 (100%)

Relative risk = 0.1677; 95% confidence interval, 0.0854 to 0.3292; *P* \< 0.0001.

[Table 6](#T6){ref-type="table"} shows the unadjusted association among antibiotic usage and SSIs. Incidence of SSI in the antibiotic group was 0.5% compared with 2.73% in the nonantibiotic group (RR = 0.1789; 95% CI = 0.0366 to 0.8748; *P* = 0.0336).

###### 

Postoperative antibiotic exposure versus postoperative inflammatory complications (surgical site infection)

  Inflammatory complication (AO or SSI)   Yes         No             Total
  --------------------------------------- ----------- -------------- --------------
  Yes---postoperative antibiotic only     3 (0.41%)   612 (84.41%)   615 (84.82%)
  No antibiotics                          3 (0.41%)   107 (14.76%)   110 (15.18%)
  Total                                   6 (0.82%)   719 (99.17%)   725 (100%)

Relative risk = 0.1789; 95% confidence interval, 0.0366 to 0.8748; *P* = 0.0336.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

One of the most common surgical procedure carried out in OS clinics is M3 extractions. In most of the situations, M3 extraction is not linked with a high risk for inflammatory complications postoperatively. Generally, in cases where complications arise, they are mild and get resolved fairly rapidly when appropriately treated, and characteristically display no enduring effects. Studies have shown that the inflammatory complications rate to be by and large low (\<5%), but M3 removal is common enough that many patients undergo extractions day-by-day basis resulting in recording possible inflammatory complications.\[[@ref1][@ref2][@ref3][@ref6]\]

We noticed a statistically significant lower inflammatory complications in those who took antibiotics postoperatively than those who didn't (*P* \< 0.001). Our results are in accordance to Lacasa *et al*.,\[[@ref7]\] who found that postoperative amoxicillin and clavulanic acid twice a day was more effective than single preoperative dose in lessening infection rates after surgical M3 extractions.

Conversely Monaco *et al*.\[[@ref8]\] revealed that a postoperative amoxicillin 2 g for 5 days did not lessened postoperative complications considerably in comparison to controls. Calvo *et al*.\[[@ref9]\] also observed akin findings of insignificant enhancement in postoperative events in persons who have not taken antibiotics postoperatively.

Studies revealed that the most common complication after M3 extraction is AO, frequency ranging between 4% and 30%.\[[@ref10][@ref11]\] In our study, AO was seen in 4.7% of all enrolled patients (postoperative antibiotic group, 2.43%; nonantibiotic group, 14.54%).

Generally the occurrence of SSIs after M3 removal was shown to range between 1% and 27% but normally is seen in less than 5% of cases. We found SSI in 0.83% of all the patients (postoperative antibiotic group, 0.49%; nonantibiotic group, 2.73%).\[[@ref12][@ref13]\]

Basically oral cavity contains a large variety of bacteria. Even though many presurgical safety measures (i.e., chlorhexidine rinses, antibiotics, sterile instruments) are taken to reduce the bacterial content, the vast number of normally inhabitant bacteria cause inherent surgical site contamination. Even after few studies, the issue of prescribing antibiotics for effectual prevention and reduction of postoperative inflammatory complications is still debated. Although antibiotics are irrefutably potent means in fighting infection, the possibility for adverse reactions and bacterial resistance should be cautiously weighed in comparison to their prospective benefits.\[[@ref11][@ref12][@ref13]\]

Studies regarding the incidence of allergies to penicillin and cephalosporins found it to be at 9% and 1%, respectively. Bacterial resistance is a major menace for which no one can predict rates of resistance and dissemination. Medical professionals should make sure that the advantage of averting occasional infectious complications outweighs the negatives of abundant antibiotic prescribing.\[[@ref14]\]

In spite of the lacking consensus, antibiotic prescription related with M3 extractions remains widespread practice worldwide including among Saudi Arabia--based and US-based OS practitioners. In our P-BRC, 62.75% of sample have taken antibiotics in some form. We also found significant variations among OS practitioners of the study area in relation to time and route of administration, dosage, and type of antibiotic used. But there was a lack of standardization regarding the aspects such as type, dosage, frequency, and length of postoperative antibiotic administration. Various antibiotics prescribed by OS practitioners were amoxicillin, clindamycin, erythromycin, amoxicillin, and clavulanic acid (1000 and 62.5 mg) or other antibiotics. Our findings are in accordance to previous similar studies.\[[@ref14][@ref15]\]

All the observations concerned with inflammatory complications were recorded by treating clinician after training them regarding our study methodology and variables AO and SSI standard definitions.

Strengths of the study {#sec2-3}
----------------------

Treating physician recorded the findingsStudy was carried out after giving training to the doctors

Limitations {#sec2-4}
-----------

Other aspects that were not assessed regarding usage of antibiotics by OS were duration of surgery, amount of tissue trauma, systemic conditions of patients. Other limitation of our study is that we did not considered factors related to the competence and general characteristics of OS such as ability, technique used, level of training taken by them, training location, and practice location.

Future research directions {#sec2-5}
--------------------------

In future, studies with larger sample size and more standardized model of postoperative antibiotic management, uniform postsurgical follow-up, and impending blinding of participants should be carried out.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

Our results implies that antibiotic therapy after M3 removal revealed a slightly reduced risk for inflammatory complications (AO or SSI). Although the sample was adequately large to present statistically pertinent data, the study results may not represent real clinical situation. In future, studies with a larger, more uniform sample with consistent postextraction follow-up and probable blinding of subjects to variables being gauged would be valuable to verify or refute the present observations.
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